The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.